Fake data, real hope: AI could speed up rare disease trials

NCT ID NCT07016282

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at whether artificial intelligence can create realistic, privacy-safe copies of health records from people with a rare kidney disease called ADPKD. Researchers will use these simulated datasets to run virtual clinical trials and see if they produce similar results to real studies. The goal is to make rare disease research faster and more efficient without putting patient data at risk.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this approach could make it faster and safer to run clinical trials for rare diseases by using simulated data instead of only real patient data.
What could go wrong
This is an early-stage observational study using existing records, not testing a treatment. The simulated data may not perfectly reflect real patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Clinical Research Centre for Rare Diseases Aldo e Cele Daccò

    Ranica, BG, 24020, Italy

  • Department of Global Public Health (GPH), Karolinska Institutet

    Stockholm, 171 77, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.